MedPharm Overview
- Year Founded
-
1999
- Status
-
Private
- Employees
-
227
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
1
MedPharm General Information
Description
Provider of contract development and manufacturing services intended to advance drug products from early development through clinical and commercial manufacturing. The company utilizes proprietary platforms and validated in vitro models to support the development and generation of regulatory-ready data, providing pharmaceutical companies with formulation development, in vitro testing, clinical trial material supply, commercial manufacturing, analytical testing, and stability testing.
Contact Information
Website
www.medpharm.comCorporate Office
- Formulation Development Facility
- Unit 3, Surrey Research Park
- Guildford GU2 7AB
- England, United Kingdom
Corporate Office
- Formulation Development Facility
- Unit 3, Surrey Research Park
- Guildford GU2 7AB
- England, United Kingdom
MedPharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MedPharm Comparisons
Industry
Financing
Details
MedPharm Competitors (15)
One of MedPharm’s 15 competitors is Bend Bioscience (Formerly CoreRx), a Private Equity-Backed company based in Clearwater, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bend Bioscience (Formerly CoreRx) | Private Equity-Backed | Clearwater, FL | ||||
| Adare Pharma Solutions | Private Equity-Backed | Philadelphia, PA | ||||
| Tergus Pharma | Private Equity-Backed | Durham, NC | ||||
| Resolian | Private Equity-Backed | Malvern, PA | ||||
| Premier Research | Private Equity-Backed | Morrisville, NC |
MedPharm Patents
MedPharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250249009-A1 | New topical formulations of ruxolitinib with an organic amine ph adjusting agent for treatment of skin diseases | Active | 07-Jun-2022 | ||
| US-20260345618-A1 | New topical formulations of ruxolitinib with an organic amine ph adjusting agent for treatment of skin diseases | Pending | 07-Jun-2022 | ||
| US-12551485-B2 | Topical formulations of ruxolitinib with an organic amine ph adjusting agent for treatment of skin diseases | Active | 07-Jun-2022 | ||
| US-12642802-B2 | Topical formulations of ruxolitinib with an organic amine ph adjusting agent for treatment of skin diseases | Active | 07-Jun-2022 | ||
| US-20230172937-A1 | Topical formulations of ruxolitinib with an organic amine ph adjusting agent for treatment of skin diseases | Active | 07-Jun-2022 | A61K31/519 |
MedPharm Signals
MedPharm Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MedPharm Investments (1)
MedPharm’s most recent deal was a Buyout/LBO with Tergus Pharma. The deal was made on 08-Jul-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tergus Pharma | 08-Jul-2024 | Buyout/LBO | BPO/Outsource Services |
MedPharm FAQs
-
When was MedPharm founded?
MedPharm was founded in 1999.
-
Where is MedPharm headquartered?
MedPharm is headquartered in Guildford, United Kingdom.
-
What is the size of MedPharm?
MedPharm has 227 total employees.
-
What industry is MedPharm in?
MedPharm’s primary industry is BPO/Outsource Services.
-
Is MedPharm a private or public company?
MedPharm is a Private company.
-
What is MedPharm’s current revenue?
The current revenue for MedPharm is .
-
Who are MedPharm’s investors?
Bourne Partners, Great Point Partners, Ampersand Capital Partners, and King's College London have invested in MedPharm.
-
Who are MedPharm’s competitors?
Bend Bioscience (Formerly CoreRx), Adare Pharma Solutions, Tergus Pharma, Resolian, and Premier Research are some of the 15 competitors of MedPharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process